IBDEI1IR ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24590,2)
 ;;=^5000968
 ;;^UTILITY(U,$J,358.3,24591,0)
 ;;=C44.91^^85^1082^1
 ;;^UTILITY(U,$J,358.3,24591,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24591,1,3,0)
 ;;=3^Basal Cell Carcinoma Skin,Unspec
 ;;^UTILITY(U,$J,358.3,24591,1,4,0)
 ;;=4^C44.91
 ;;^UTILITY(U,$J,358.3,24591,2)
 ;;=^5001092
 ;;^UTILITY(U,$J,358.3,24592,0)
 ;;=C44.99^^85^1082^14
 ;;^UTILITY(U,$J,358.3,24592,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24592,1,3,0)
 ;;=3^Malig Neop Skin,Other Spec
 ;;^UTILITY(U,$J,358.3,24592,1,4,0)
 ;;=4^C44.99
 ;;^UTILITY(U,$J,358.3,24592,2)
 ;;=^5001094
 ;;^UTILITY(U,$J,358.3,24593,0)
 ;;=C50.912^^85^1082^8
 ;;^UTILITY(U,$J,358.3,24593,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24593,1,3,0)
 ;;=3^Malig Neop Left Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,24593,1,4,0)
 ;;=4^C50.912
 ;;^UTILITY(U,$J,358.3,24593,2)
 ;;=^5001196
 ;;^UTILITY(U,$J,358.3,24594,0)
 ;;=C50.911^^85^1082^12
 ;;^UTILITY(U,$J,358.3,24594,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24594,1,3,0)
 ;;=3^Malig Neop Right Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,24594,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,24594,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,24595,0)
 ;;=C61.^^85^1082^10
 ;;^UTILITY(U,$J,358.3,24595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24595,1,3,0)
 ;;=3^Malig Neop Prostate
 ;;^UTILITY(U,$J,358.3,24595,1,4,0)
 ;;=4^C61.
 ;;^UTILITY(U,$J,358.3,24595,2)
 ;;=^267239
 ;;^UTILITY(U,$J,358.3,24596,0)
 ;;=C67.9^^85^1082^3
 ;;^UTILITY(U,$J,358.3,24596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24596,1,3,0)
 ;;=3^Malig Neop Bladder,Unspec
 ;;^UTILITY(U,$J,358.3,24596,1,4,0)
 ;;=4^C67.9
 ;;^UTILITY(U,$J,358.3,24596,2)
 ;;=^5001263
 ;;^UTILITY(U,$J,358.3,24597,0)
 ;;=C64.2^^85^1082^9
 ;;^UTILITY(U,$J,358.3,24597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24597,1,3,0)
 ;;=3^Malig Neop Left Kidney,Except Renal Pelvis
 ;;^UTILITY(U,$J,358.3,24597,1,4,0)
 ;;=4^C64.2
 ;;^UTILITY(U,$J,358.3,24597,2)
 ;;=^5001249
 ;;^UTILITY(U,$J,358.3,24598,0)
 ;;=C64.1^^85^1082^13
 ;;^UTILITY(U,$J,358.3,24598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24598,1,3,0)
 ;;=3^Malig Neop Right Kidney,Except Renal Pelvis
 ;;^UTILITY(U,$J,358.3,24598,1,4,0)
 ;;=4^C64.1
 ;;^UTILITY(U,$J,358.3,24598,2)
 ;;=^5001248
 ;;^UTILITY(U,$J,358.3,24599,0)
 ;;=C79.51^^85^1082^16
 ;;^UTILITY(U,$J,358.3,24599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24599,1,3,0)
 ;;=3^Secondary Malig Neop Bone
 ;;^UTILITY(U,$J,358.3,24599,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,24599,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,24600,0)
 ;;=C79.52^^85^1082^17
 ;;^UTILITY(U,$J,358.3,24600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24600,1,3,0)
 ;;=3^Secondary Malig Neop Bone Marrow
 ;;^UTILITY(U,$J,358.3,24600,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,24600,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,24601,0)
 ;;=Z12.9^^85^1082^15
 ;;^UTILITY(U,$J,358.3,24601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24601,1,3,0)
 ;;=3^Screening Malig Neop Site Unspec
 ;;^UTILITY(U,$J,358.3,24601,1,4,0)
 ;;=4^Z12.9
 ;;^UTILITY(U,$J,358.3,24601,2)
 ;;=^5062698
 ;;^UTILITY(U,$J,358.3,24602,0)
 ;;=D17.9^^85^1082^2
 ;;^UTILITY(U,$J,358.3,24602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24602,1,3,0)
 ;;=3^Benign Neop Lipomatous,Unspec
 ;;^UTILITY(U,$J,358.3,24602,1,4,0)
 ;;=4^D17.9
 ;;^UTILITY(U,$J,358.3,24602,2)
 ;;=^5002020
 ;;^UTILITY(U,$J,358.3,24603,0)
 ;;=E11.9^^85^1083^15
